AstraZeneca expands cardiovascular disease prospects

The latest stories trending on MedCity News.

Editor's Pick

Top Story AstraZeneca Expands Cardiovascular Disease Prospects, Paying $100M for Oral Way to Drug Lp(a) Cardiovascular disease drugs in development intended to reduce lipoprotein (a) are mostly injectable medications, though Eli Lilly also has both oral and injectable drugs in the clinic. AstraZeneca aims to hit that key protein target with an oral small molecule licensed from CSPC Pharmaceutical Group.

Featured News

Perelel Acquires LOOM to Boost Women's Health Education in Sexual, Reproductive Health Perelel has acquired LOOM, an educational platform for reproductive health, sexual wellness and parenting. Through the acquisition, the company aims to advance health literacy for women. Video: Why the FTC's Lawsuit Against PBMs May Have Some Legs Months before the FTC sued the three largest pharmacy benefit managers, the CEO of Blue Shield of California battled its PBM – CVS Caremark – to bring a lower cost prostate cancer drug to its members. It's Time for Employers and Policymakers to Step Up for Caregivers  The U.S. workforce does not need to be in a position where they must choose between their careers and caring for their families. If sufficient balance between work and caregiving is not achieved, caregivers face the risk of becoming patients themselves. Why Outsourcing IT and Cybersecurity is the Smart Choice for FQHCs Even top companies struggle to maintain adequate IT staffing levels. Here are several reasons why FQHCs should consider outsourcing to a firm experienced in the nuances of healthcare.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Dr. Jayne Morgan, VP of Medical Affairs at Hello Heart In this month's episode, Senior Reporter Katie Adams explored some of the executive moves, exits and layoffs that recently occurred in the healthcare sector. She also interviewed Dr. Jayne Morgan, who recently became vice president of medical affairs at Hello Heart. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe